Retroviral Vector Purification via Tangential Flow Filtration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying retroviral vectors for clinical use face challenges in achieving high-purity, high-titer preparations suitable for large-scale production, particularly due to the instability of retroviruses and the inefficiencies of traditional purification techniques such as ultracentrifugation, which are costly and difficult to scale up.
Innovation Solution
A method involving microfiltration, nuclease treatment, ultrafiltration, and low-speed centrifugation is employed to purify retroviral vectors, using semipermeable membranes with specific pore sizes and flow rates to minimize shear force damage and effectively remove impurities, followed by sterilization to achieve GMP-grade purity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional ultracentrifugation is used for retrovirus purification, then high purity can be achieved, but the process is expensive and difficult to scale up
Solution Approach 1:
The patent replaces the mechanical ultracentrifugation system with a tangential flow filtration system using cross-flow ultrafiltration membranes. This substitution maintains high purification effectiveness while enabling scalable manufacturing through continuous processing and easier equipment scaling.
Solution Approach 2:
The patent extracts and removes specific impurities (host cell DNA, proteins, and debris) from the retrovirus preparation through selective filtration and nuclease treatment, achieving high purity without requiring expensive ultracentrifugation equipment.
2Manufacturing precision
If traditional ultracentrifugation is used for retrovirus purification, then high purity can be achieved, but the process is time consuming
Solution Approach 1:
The patent replaces time-consuming ultracentrifugation with faster tangential flow filtration processes that achieve equivalent or superior purification in reduced time through continuous cross-flow mechanisms.
Solution Approach 2:
The patent performs preliminary nuclease treatment to digest host cell DNA before filtration, which simplifies subsequent purification steps and reduces overall processing time while maintaining high purity standards.
3Productivity
If high shear force is applied during filtration, then purification efficiency is improved, but retrovirus stability deteriorates
Solution Approach 1:
The patent optimizes filtration parameters including cross-flow rate, pressure differential, and membrane pore size to achieve the right balance between purification efficiency and virus stability, preventing excessive shear forces while maintaining effective impurity removal.
Solution Approach 2:
The patent uses tangential flow as an intermediary mechanism that allows cross-flow across the membrane surface, reducing direct shear force on viruses while maintaining high purification efficiency through continuous fluid movement.
4Ease of manufacture
If supernatant collection method is used, then production is simplified, but viral activity titer is insufficient for clinical requirements
Solution Approach 1:
The patent extracts and removes specific impurities (host cell DNA, proteins, and debris) from the retrovirus preparation through selective filtration and nuclease treatment, achieving high purity without requiring expensive ultracentrifugation equipment.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method significantly improves the purity and biological activity of retroviral vectors, achieving impurity removal rates exceeding 90% and titer levels of 10^7 IP/mL, meeting clinical requirements while avoiding the limitations of traditional methods like ultracentrifugation and ion exchange chromatography.
Implementation Method 1
performing microfiltration of a cell culture supernatant containing a retrovirus to remove cell debris
Implementation Method 2
performing treatment on the micro-filtered virus solution with a nuclease to degrade host DNA residues into small DNA fragments
Implementation Method 3
performing ultrafiltration of the enzyme-digested virus solution so as to allow the retrovirus to be remained in a retentate
Implementation Method 4
performing a low speed centrifugation of the ultrafiltered virus solution, and collecting the precipitate to obtain an unsterilized virus
Data Source
AI summary
Disclosed is a method for purifying a retrovirus (retroviral vector), comprising the following steps: A), micro-filtering a cell culture supernatant containing a retrovirus so as to remove cell debris from the cell culture supernatant, and obtaining a micro-filtered virus solution; B), treating the microfiltered virus solution with a nuclease so as to degrade host DNA residues into small DNA fragments, and obtaining an enzyme-digested virus solution; C), ultra-filtering the enzyme-digested virus solution such that the retrovirus is retained in a retentate, collecting the retentate, and obtaining an ultra-filtered virus solution; and D), performing low-speed centrifugation treatment on the ultra-filtered virus solution so as to precipitate the retrovirus, collecting the precipitate, and obtaining a virus that has not undergone sterilization. The retrovirus product obtained by the described method ensures the purity of the retrovirus solution, and at the same time, the titer of the concentrated virus solution can reach 107IP/ml, which meets downstream processing requirements.